PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104523
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104523
Intravenous (IV) Therapy and Vein Access Market size was valued at US$ 13,602.8 Million in 2025, expanding at a CAGR of 6.8% from 2026 to 2033.
The IV Therapy and Vein Access Market includes various types of products, such as IV catheters, hypodermic needles, implantable ports, and infusion pumps. These devices are used to safely deliver therapeutics, fluids, blood products, biologics, and parenteral nutrition into patients' bloodstreams through an IV line or catheter inserted into a vein. This market segment spans several medical environments, including hospitals, outpatient surgery centers, oncology centers, emergency rooms, and in-home care settings. The increasing incidence of chronic diseases, the rising number of surgeries, and the increased use of infusion therapy are the key drivers of market growth. The prevention of CLABSI has been stated by the CDC to be one of their significant public health priorities for 2025, and increased attention is needed toward the development of effective vascular access devices, infection control technology, and safer infusion practices to prevent infections.
Intravenous (IV) Therapy and Vein Access Market- Market Dynamics
Rising Burden of Chronic Diseases Driving Demand for Long-Term Intravenous Therapy
Prolonged infusion therapy is crucial for managing chronic diseases such as cancer, kidney disease, gastrointestinal disorders, autoimmune diseases, and critical infections. The increasing demand for prolonged therapies to treat chronic and life-threatening diseases has stimulated the need for improved, safe, and convenient venous access solutions to efficiently deliver medications, blood, nutrients, and therapies to patients suffering from conditions requiring extended periods of intravenous treatment. As a consequence, hospitals and clinics are adopting implantable ports, central venous catheters, and smart infusion devices with increased safety features and improved ease of use to support the sustained use of such treatments. In 2025, according to the IARC (International Agency for Research on Cancer), more than 20 million new cases of cancer were registered globally, reinforcing the growing need for reliable vascular access devices to support long-term infusion therapies across oncology and other chronic care settings.
The Global Intravenous (IV) Therapy and Vein Access Market is segmented on the basis of Product Type, Application, End User, and Region.
Intravenous catheters represent the largest product segment in the IV Therapy and Vein Access Market due to their extensive use across hospitals, emergency departments, surgical centers, and outpatient facilities for medication delivery and fluid management. Hypodermic needles continue to maintain strong demand across injection procedures, diagnostic applications, and routine therapeutic treatments. Meanwhile, implantable ports are gaining adoption for long-term treatment requirements, particularly among oncology patients undergoing repeated chemotherapy and biologic therapies. Infusion pumps are also experiencing increased demand with the integration of smart medication delivery systems. According to the WHO, billions of injections are administered globally every year, supporting the continued need for reliable vascular access devices.
Medication administration remains the leading application segment in the IV Therapy and Vein Access Market due to the advantages of intravenous delivery, including rapid absorption, controlled dosing, and improved therapeutic effectiveness for antibiotics, biologics, chemotherapy agents, and emergency medications. Blood products, parenteral nutrition solutions, and volume replacement therapies are also contributing significantly to market demand, particularly in trauma care, intensive care units, and surgical procedures requiring immediate fluid or nutrient support. The rising prevalence of chronic diseases and increasing complexity of medical treatments are accelerating the adoption of advanced IV systems. According to IARC, more than 20 million new cancer cases were reported globally in 2025, further increasing demand for dependable infusion and vascular access solutions.
Intravenous (IV) Therapy and Vein Access Market- Geographical Insights
North America's market position is amplified by its technologically advanced infrastructure and robust healthcare policies. A smart and interlinked healthcare network, coupled with the rapid adoption of sophisticated digitally interconnected medical devices such as infusion management systems, is fueling the growth of the U.S. IV Therapy and Vein Access Market, led by market players that operate in the smart vascular access product market. Increases in the number of surgical procedures, at-home infusion, and chronic diseases are contributing to market expansion in the U.S. According to the American Hospital Association, more than 6,100 hospitals are present in the U.S., and that directly translates to substantial and unwavering demand for essential medical devices such as intravenous catheters, implantable ports, and infusion pumps. With the increasing prevalence of chronic diseases and the expansion of at-home infusion therapy, the market is further expanding with a need for advanced IV access devices.
Asia-Pacific market for IV Therapy and Vein Access is expected to experience a fast-growing pace over the forecast period due to increasing healthcare services, the expansion of healthcare facilities, and growing rates of surgeries, along with advancements in medical technology such as cutting-edge IV access devices, infusion pumps, and connected systems. According to the WHO, the Asia-Pacific region is witnessing growth in demand for healthcare services since 2025 with a rising aging population and a growing burden of non-communicable diseases in the region. Moreover, developing economies such as China, India, South Korea, and Japan are also seeing the establishment of new specialty hospitals, which will expand the use of advanced IV devices for various patient treatments, along with the widespread adoption of at-home infusions.
The Intravenous (IV) Therapy and Vein Access Market is characterized by intense competition among numerous players, who are strategically focused on introducing innovative product offerings and enhancing their market presence through product development, technological advancements, and the expansion of product portfolios to cater to specific needs of patient care, such as digital infusion pumps, smart venous access devices, antimicrobial catheters, and connected healthcare solutions. Regulatory approvals, strategic partnerships, mergers and acquisitions, and new product launches are some of the strategies that have helped companies increase their market share. Current investment areas include the development of advanced medical technology, such as smart IV devices and remote patient monitoring.
In February 2025, BD expanded its connected medication management portfolio by enhancing interoperability between its BD Alaris(TM) Infusion System and hospital digital platforms, enabling improved medication administration workflows and clinical decision support.
In April 2025, ICU Medical introduced additional enhancements across its infusion therapy portfolio, including updated software capabilities for the Plum Duo(TM) Infusion Pump, designed to improve clinical workflow, interoperability, and medication safety while supporting healthcare providers in high-acuity environments.